Pattern loss is inherited sensitivity expressed one growth cycle at a time.
Androgens participate, but circulating hormone levels do not tell the whole story. Susceptible follicles gradually produce finer, shorter hairs in a recognizable distribution.
Androgenetic alopecia is common, non-scarring and usually gradual.
Men commonly develop temple recession and crown thinning. Women more often notice a widening central part or reduced upper-scalp density, with individual variation.
The condition can coexist with telogen effluvium, low iron, thyroid disease, traction or inflammatory loss. Sudden heavy shedding or scalp pain is not explained by miniaturization alone.
Caliber changes first
Terminal hairs become finer and shorter before an area appears bald.
Family history can be subtle
Inheritance is polygenic and may come through either side of the family.
Progression varies
Some patterns move slowly for years; others become visible earlier or accelerate with overlap.
Maintenance usually matters
Benefits from medical treatment commonly diminish after treatment stops.
The same biology often draws different maps in men and women.
Male pattern loss often follows the Norwood-Hamilton spectrum; female pattern loss is often described with Ludwig or Sinclair scales. These scales describe appearance, not every contributing cause.
Trichoscopy can show variation in shaft diameter, miniaturized hairs and regional differences that support the diagnosis.

Compare gradual miniaturization with signs of an overlap.
A recognizable pattern can still carry a second diagnosis.
- Gradual temple or crown change
- Widening central part
- Finer hairs within affected zones
- Family pattern of thinning
- Follicular openings remain visible
- Abrupt diffuse shedding
- Smooth isolated patches
- Pain, burning or pustules
- Heavy scale or absent openings
- Short broken hairs at tension points
Diagnosis combines distribution, tempo and follicle-caliber variation.
A verified trichologist can document miniaturization and progression; medical clinicians manage prescription choices and atypical cases.
- 01 · Map the patternRecord hairline, temples, crown and central part under consistent light.
- 02 · Examine caliberUse magnification to compare affected and relatively preserved zones.
- 03 · Screen for overlapReview shedding, nutrition, health, medicines and scalp symptoms.
- 04 · Select treatment contextAccount for age, sex, cardiovascular history, reproductive plans and preferences.
When the story needs medical attention.
Hair loss may be one clue within a larger health issue. Seek timely evaluation when any of these apply.
- Rapid or patchy loss
- Scalp pain, burning, pustules or crusting
- Loss of follicular openings
- New virilization or major menstrual change
- Medication-related fainting, edema or chest symptoms
- Significant psychological distress
Choose evidence-based treatment that the individual can sustain.
No option guarantees recovery, and selection changes with medical and reproductive context.
Topical minoxidil
May support hair diameter and density in men and women when used consistently.
Oral minoxidil or anti-androgen therapy
May be considered off-label for selected patients under medical supervision.
Systemic, sexual and reproductive risks require individualized discussion.Finasteride or dutasteride
Can reduce androgen signaling in appropriate patients; indications and reproductive precautions differ.
LLLT, PRP or transplantation
May add benefit for selected patients, but protocols, candidacy and outcomes vary.
Use consistent photographs before deciding whether treatment works.
Document density
Record affected zones and every concurrent treatment.
Look for stabilization
Some early shedding can occur; visible improvement may still be limited.
Review benefit
Compare photographs, tolerance, cost and maintenance needs.
Clear answers to the next questions.
Is androgenetic alopecia caused by high DHT?
Not necessarily. Genetic follicle sensitivity and local biology matter, and blood levels may be normal.
Can women have it?
Yes. Female pattern hair loss commonly affects the central and upper scalp.
Can it be cured?
It can often be slowed or improved, but ongoing management is usually needed and complete restoration is not guaranteed.
Does minoxidil block DHT?
No. It supports follicle activity through a different pathway.
Will supplements reverse it?
Supplements do not reverse inherited miniaturization unless a separate deficiency is also present.
When is transplantation considered?
When diagnosis and progression are understood, donor supply is adequate and the long-term design is appropriate.



